AU2002222079A1 - Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same - Google Patents

Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same

Info

Publication number
AU2002222079A1
AU2002222079A1 AU2002222079A AU2002222079A AU2002222079A1 AU 2002222079 A1 AU2002222079 A1 AU 2002222079A1 AU 2002222079 A AU2002222079 A AU 2002222079A AU 2002222079 A AU2002222079 A AU 2002222079A AU 2002222079 A1 AU2002222079 A1 AU 2002222079A1
Authority
AU
Australia
Prior art keywords
propanolamines
cyclohexyl
alkyl
preparation
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002222079A
Other versions
AU2002222079B2 (en
Inventor
Philippe R. Bovy
Roberto Cecchi
Gilles Courtemanche
Tiziano Croci
Ambrogio Oliva
Nunzia Viviani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Aventis France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0015477A external-priority patent/FR2817257B1/en
Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France
Publication of AU2002222079A1 publication Critical patent/AU2002222079A1/en
Assigned to SANOFI-AVENTIS reassignment SANOFI-AVENTIS Amend patent request/document other than specification (104) Assignors: SANOFI-SYNTHELABO
Application granted granted Critical
Publication of AU2002222079B2 publication Critical patent/AU2002222079B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002222079A 2000-11-30 2001-11-30 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same Ceased AU2002222079B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0015477A FR2817257B1 (en) 2000-11-30 2000-11-30 CYCLOHEXYL (ALKYL) -PROPANOLAMINES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR0015477 2000-11-30
PCT/FR2001/003784 WO2002044139A1 (en) 2000-11-30 2001-11-30 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same

Publications (2)

Publication Number Publication Date
AU2002222079A1 true AU2002222079A1 (en) 2002-08-15
AU2002222079B2 AU2002222079B2 (en) 2006-12-14

Family

ID=8857054

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2002222079A Ceased AU2002222079B2 (en) 2000-11-30 2001-11-30 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
AU2207902A Pending AU2207902A (en) 2000-11-30 2001-11-30 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2207902A Pending AU2207902A (en) 2000-11-30 2001-11-30 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same

Country Status (25)

Country Link
US (3) US7388031B2 (en)
EP (1) EP1341753B1 (en)
JP (1) JP4024149B2 (en)
CN (2) CN1935787A (en)
AR (1) AR031438A1 (en)
AT (1) ATE374177T1 (en)
AU (2) AU2002222079B2 (en)
BR (1) BR0115768A (en)
CA (1) CA2429267C (en)
CY (1) CY1106997T1 (en)
CZ (1) CZ305140B6 (en)
DE (1) DE60130676T2 (en)
DK (1) DK1341753T3 (en)
ES (1) ES2290201T3 (en)
FR (1) FR2817257B1 (en)
HK (1) HK1055945A1 (en)
HU (1) HU229583B1 (en)
ME (1) MEP23308A (en)
MX (1) MXPA03004884A (en)
PL (1) PL206695B1 (en)
PT (1) PT1341753E (en)
RS (1) RS51571B (en)
SI (1) SI1341753T1 (en)
SK (1) SK287551B6 (en)
WO (1) WO2002044139A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2817257B1 (en) * 2000-11-30 2009-03-20 Sanofi Synthelabo CYCLOHEXYL (ALKYL) -PROPANOLAMINES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2840304B1 (en) * 2002-05-29 2007-05-18 Sanofi Synthelabo OXOPHENYL-CYCLOHEXYL-PROPANOLAMINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
FR2840301B1 (en) * 2002-05-29 2007-03-23 Sanofi Synthelabo PHENYL-CYCLOHEXYL-PROPANOLAMINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THERAPEUTICS
EP2011490A1 (en) 2007-07-05 2009-01-07 Sanofi-Aventis Beta adrenergic receptor ligand derivatives for modulating apoptosis
FR2935141B1 (en) * 2008-08-21 2010-10-08 Sanofi Aventis PROCESS FOR PREPARING THE ETHYL ESTER OF 4- [TRANS-4 - [(PHENYLMETHYL) -AMINO] CYCLOHEXYL] BENZOIC ACID AND ITS SALT HEMIFUMARATE
WO2010051503A1 (en) * 2008-10-31 2010-05-06 Medivation Technologies, Inc. Azepino [4, 5-b] indoles and methods of use
CN116143575B (en) * 2023-04-21 2023-06-30 研峰(天津)科学技术应用研究有限公司 Method for synthesizing insect pheromone raw material 3-cyclohexyl-1-propyne

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4004028A (en) * 1975-08-06 1977-01-18 Smithkline Corporation Phenoxypropanolamines
CA1336911C (en) * 1988-06-03 1995-09-05 David Taiwai Wong Serotonin antagonists
US5158956A (en) 1990-05-04 1992-10-27 Eli Lilly And Company Method of inhibiting gastric acid secretion with benzodioxanes
US5340838A (en) 1990-05-04 1994-08-23 Eli Lilly And Company Method of inhibiting gastric acid secretion with 2-phenylcyclopropylamines
US5096908A (en) 1990-05-04 1992-03-17 Eli Lilly And Company Method of inhibiting gastric acid secretion
US5258379A (en) 1990-05-04 1993-11-02 Eli Lilly And Company Method of inhibiting gastric acid secretion with n-arylpiperazines
DE4035961A1 (en) * 1990-11-02 1992-05-07 Thomae Gmbh Dr K CYCLIC IMINODERIVATES, MEDICAMENTS CONTAINING SUCH COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
IL107611A0 (en) 1992-11-18 1994-02-27 Smithkline Beecham Corp Steroid compounds and pharmaceutical compositions containing them
US5451677A (en) * 1993-02-09 1995-09-19 Merck & Co., Inc. Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity
IL110857A0 (en) 1993-09-09 1994-11-28 Lilly Co Eli Cessation of tobacco use
CA2134038C (en) 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
EP0714663A3 (en) 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug response by a serotonin 1A receptor antagonist
US5776959A (en) 1995-06-05 1998-07-07 Washington University Anticonvulsant and anxiolytic lactam and thiolactam derivatives
IL123677A0 (en) * 1995-09-21 1998-10-30 Lilly Co Eli Selective beta3 adrenergic agonists
EP0792649A1 (en) 1996-02-29 1997-09-03 Eli Lilly And Company Treatment of sleep disorders
US5958429A (en) 1996-08-16 1999-09-28 Eli Lilly And Company Potentiation of serotonin response
US20020019440A1 (en) 1996-11-05 2002-02-14 Virbac Sa Aryloxypropanolamine derivatives, method of preparation and applications thereof
FR2755439B1 (en) 1996-11-05 1998-12-24 Virbac Sa ARYLOXYPROPANOLAMINE DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATIONS
FR2758460B1 (en) * 1997-01-21 1999-12-31 Sanofi Sa USE OF ADRENERGIC BETA-3 RECEPTOR AGONISTS FOR THE PREPARATION OF HEALING MEDICINAL PRODUCTS
US5776969A (en) 1997-02-27 1998-07-07 Eli Lilly And Company Treatment of sleep disorders
FR2780057B1 (en) * 1998-06-18 2002-09-13 Sanofi Sa PHENOXYPROPANOLAMINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
JP2000086603A (en) 1998-07-15 2000-03-28 Yoshitomi Pharmaceut Ind Ltd Cinnamic acid amide derivative and 3-phenylpropionic acid amide derivative
AU2400300A (en) 1998-12-30 2000-07-31 Eli Lilly And Company Solution phase synthesis of compounds including amine alcohol functionality
US6248739B1 (en) 1999-01-08 2001-06-19 Pharmacia & Upjohn Company Quinolinecarboxamides as antiviral agents
US20020019940A1 (en) * 2000-06-16 2002-02-14 Matteson Craig S. Method and apparatus for assigning test and assessment instruments to users
AUPQ841300A0 (en) * 2000-06-27 2000-07-20 Fujisawa Pharmaceutical Co., Ltd. New aminoalcohol derivatives
MXPA03000308A (en) 2000-07-13 2003-06-06 Lilly Co Eli Beta3 adrenergic agonists.
FR2817257B1 (en) 2000-11-30 2009-03-20 Sanofi Synthelabo CYCLOHEXYL (ALKYL) -PROPANOLAMINES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US6693125B2 (en) 2001-01-24 2004-02-17 Combinatorx Incorporated Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders
FR2840301B1 (en) 2002-05-29 2007-03-23 Sanofi Synthelabo PHENYL-CYCLOHEXYL-PROPANOLAMINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THERAPEUTICS
FR2840304B1 (en) * 2002-05-29 2007-05-18 Sanofi Synthelabo OXOPHENYL-CYCLOHEXYL-PROPANOLAMINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
AU2003251904A1 (en) 2002-07-15 2004-02-02 Combinatorx, Incorporated Combinations of drugs for the treatment of neoplasms
AU2003262947A1 (en) 2002-08-30 2004-03-19 Pharmacia And Upjohn Company Method of preventing or treating atherosclerosis or restenosis
US20070066590A1 (en) 2003-02-24 2007-03-22 Jones Robert M Phenyl-and pyridylpiperidine-derivatives as modulators of glucose metabolism
JP2007528400A (en) 2004-03-09 2007-10-11 エラン ファーマシューティカルズ,インコーポレイテッド Substituted hydroxyethylamine aspartic protease inhibitors

Similar Documents

Publication Publication Date Title
AU2001237526A1 (en) Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
AU2001237525A1 (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
AU781269C (en) Pharmaceutical compositions
AU7429500A (en) Piperidine quinolyl propyl derivatives, preparation method and compositions containing same
AU2002313236A1 (en) Medicinal compositions
AU2001250420A1 (en) Pharmaceutical compositions
AU2001235737A1 (en) Novel 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same
AU2001269198A1 (en) Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them
AU2001277602A1 (en) Heparin-derived polysaccharide mixtures, preparation method and pharmaceutical compositions containing same
AU2002214324A1 (en) Medicinal compositions
IL151912A0 (en) Pyrolidine derivatives, their preparation and pharmaceutical compositions containing them
AU2001290239A1 (en) Medicinal composition
AU2002224938A1 (en) Compounds that affect CD83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds
AU2001273919A1 (en) Pharmaceutical compositions
AU3560601A (en) Novel isoquinoline derivatives, preparation method and pharmaceutical compositions containing them
AU2002360117A1 (en) Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
AU2002222079A1 (en) Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
AU2002210632A1 (en) Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same
AU2002313065A1 (en) Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
AU2207902A (en) Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
IL154986A0 (en) Triazolo-epothilone derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
AU2001274171A1 (en) Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof
HUP0304065A2 (en) Novel 5-thio-betha-d-xylopyranoside derivatives, preparation method thereof, pharmaceutical compositions containing same and use thereof
AU4884701A (en) Malonanilic acid derivatives, medicinal compositions containing the same and usethereof
AU2002246658A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds